The Riksbank justifiably felt the need to give the economy a shot in the arm at its meeting this week. But positive news on the vaccine front means that it should be able to avoid increasing the dose of policy support next year. Much of the data due for release next week is already old news, but the manufacturing PMIs for November are likely to confirm that industrial activity has largely taken the ramp-up in virus restrictions in its stride.
Become a client to read more
This is premium content that requires an active Capital Economics subscription to view.
Already have an account?
You may already have access to this premium content as part of a paid subscription.
Sign in to read the content in full or get details of how you can access it
Register for free
Sign up for a free account to gain:
- Unlock additional content
- Register for Capital Economics events
- Receive email updates and economist-curated newsletters
- Request a free trial of our services